Results to be published
We encourage physicians to enroll suitable patients, ( patients that use opioids and may benefit from medicinal cannabis treatment) in this study.
Dr. Sheel Patel is a private practice physician where his work focuses on accurately diagnosing and comprehensively treating the underlying cause of a variety of pain syndromes. Dr. Patel also manages the private-public partnerships pertaining to the structuring of clinical trials related to the use of cannabinoids in pain in coordination with the PhytoSciences Consulting team.
Dr. Pritesh Kumar earned his Ph.D. in Pharmacology and Toxicology, with a focus in cannabinoid pharmacology, from the University of Louisville. Currently, Dr. Kumar is the CEO of PhytoSciences and leads a team of 40+ global scientists / physicians with a primary focus of developing safe, consistent, and pure medicinal cannabinoid-based therapeutics.
If you have any questions about the study, contact us and we will get back to you as soon as possible.